Asset Management One’s Ionis Pharmaceuticals IONS Stock Holding History

Asset Management One’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-60,617	Closed	-$2.73M	–	1061
2021 Q1	$2.73M	Sell	60,617 -3,524	-5%	-$197K	0.01%	771
2020 Q4	$3.66M	Hold	64,141	–	–	0.02%	717
2020 Q3	$3.04M	Sell	64,141 -20	-0%	-$1.11K	0.01%	706
2020 Q2	$3.78M	Sell	64,161 -446	-0.7%	-$24.8K	0.02%	633
2020 Q1	$3.05M	Sell	64,607 -1,276	-2%	-$71.1K	0.02%	616
2019 Q4	$3.98M	Buy	65,883 +515	+0.8%	+$30.7K	0.02%	689
2019 Q3	$3.92M	Buy	65,368 +2,724	+4%	+$178K	0.02%	675
2019 Q2	$4.03M	Buy	+62,644	New	+$4.43M	0.02%	675
2016 Q3	–	Sell	-10,990	Closed	-$254K	–	1331
2016 Q2	$254K	Hold	10,990	–	–	﹤0.01%	1175
2016 Q1	$428K	Hold	10,990	–	–	0.01%	1098
2015 Q4	$670K	Hold	10,990	–	–	0.01%	996
2015 Q3	$421K	Sell	10,990 -650	-6%	-$33.6K	0.01%	1095
2015 Q2	$655K	Hold	11,640	–	–	0.01%	1025
2015 Q1	$751K	Buy	+11,640	New	+$790K	0.01%	986

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Asset Management One's IONS Position: Q2 2021 in Review

Asset Management One sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 60,617 shares — an estimated $2.73M sold.

Asset Management One first reported a position in IONS in Q1 2015 and held it in 14 quarters. The position peaked at $4.03M in Q2 2019. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Asset Management One reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Asset Management One sold 60,617 Ionis Pharmaceuticals shares in Q2 2021, an estimated $2.73M.
Asset Management One first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 14 quarters.
Asset Management One's Ionis Pharmaceuticals position peaked at $4.03M in Q2 2019.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Asset Management One's 13F filing for Q2 2021, filed 3 Aug 2021.